Takeda Pharmaceutical Co Ltd
Rusfertide
Polycythemia Vera
Countdown
86days
Approval decision · ~ Sep 30, 2026 estimated
What's at stake
A final FDA approval decision on Rusfertide for Polycythemia Vera is expected ~ Sep 30, 2026.
Primary source
· SEC 6-K
verified 11h ago
“The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year.”